Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 7.03-63.65475.4870.509.45

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 7.03 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20247.03
Mar2023-63.65
Mar2022475.48
Mar202170.50
Mar20209.45

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48
574.44
Mar2021 70.5
646.03
Mar2020 9.45 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹1,119.6 Cr 6.6% 12.7% 103% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,204.0 Cr -1% -0.5% 13.2% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

6.6%

12.7%

103%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses